Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Releasable intraluminal suture to reduce hypotony after Preserflo glaucoma surgery

Official title: Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device

Run by Hôpital Privé de la Baie · NCT07531199 · Data updated 2026-11-12

This trial tests a releasable stitch technique to lower the risk of hypotony after glaucoma surgery with the Preserflo device in adults with certain types of glaucoma.

More Glaucoma trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment192 (estimated)
SponsorHôpital Privé de la Baie
Academic / other
Locations1 site (Avranches)
StatusRecruiting
StartedSeptember 17, 2026
Main results expectedDecember 31, 2028
Study endsFebruary 28, 2029
Registry record updatedOctober 2, 2026
Trial IDNCT07531199 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with primary open-angle, pseudoexfoliative, or pigmentary glaucoma needing glaucoma surgery and meeting conjunctival health and prior treatment criteria.

Probably not a fit

Patients without the targeted glaucoma types or who do not meet surgical eligibility or who have exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates a releasable intraluminal suture method used with the Preserflo glaucoma drainage device. It aims to determine safety and potential to reduce postoperative hypotony while maintaining intraocular pressure control. Eligible participants have open-angle, pseudoexfoliative, or pigmentary glaucoma requiring surgical intervention and meet criteria related to conjunctival health and prior treatment failure or risk of failure. The investigation uses a standard surgical approach with the added releasable suture technique to modulate outflow. Results will inform whether this method can improve outcomes in MIGS/LIGS contexts.

Why it matters

Potential benefit: If successful, patients may experience fewer cases of postoperative hypotony and better overall IOP control after Preserflo surgery.

How similar studies have gone: Preliminary results from similar Preserflo approaches have shown promise for safety and effectiveness in reducing complications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma with an indication for glaucoma surgery (defined as uncontrolled intraocular pressure or worsening of visual fields, despite maximum tolerated medical therapy) and an open iridocorneal angle (trabeculum visible on gonioscopy, Shaffer classification grade 3-4)

  * Healthy, mobile conjunctiva (without scarring or adhesions).
  * The indication for glaucoma surgery is defined as uncontrolled IOP or worsening of visual fields despite maximum tolerated medical therapy, and with either a previous failure of trabeculectomy or a risk of failure.
  * Maximum tolerated medical therapy: 3 or more classes of ocular hypotensive treatment, or fewer if there is an allergy or intolerance to the treatment. Visual field defects must be more severe than -3 dB in mean deviation.

Exclusion Criteria:

* severe systemic pathologies
* other ophtalmic pathologies (except cataract)
* previous intraocular surgery (except cataract)
* neovascular glaucoma or iris neovascularization
* pachymetry \< 490µm or \> 620µm
* contraindication to PRESERFLO Microshunt

Where it's running

  • Hôpital Privé de la Baie
    Avranches, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.